Boston, MA 03/18/2014 (wallstreetpr) – CombiMatrix Corp (NASDAQ:CBMX), which is dedicated in DNA-based testing with emphasis on developmental disorders and cancer and is a molecular diagnostics company, made a press release last week that it has been chosen by American Pathology Partners (AP2), to partner in its chromosomal microarray analysis (CMA) testing. The partnership between the two companies came into effect immediately and has commenced at UniPath, which is AP2’s flagship laboratory located in Denver. The aim of the analysis is to test for miscarriage analysis to AP2 patient with the objective to provide the best care to its patients. This partnership comes in light of CombiMatrix Corp (NASDAQ:CBMX)’s existing specialty in CMA testing, which, according to AP2, will be of immense benefit to both its clinicians and patients.
Liquidmetal Technologies Inc (OTCBB:LQMT) is trading down today by 1.06%. The company that develops and commercializes products made from amorphous alloys, recently announced its fourth quarter as well as fiscal 2013 results. The company’s financial results for fiscal 2013 mirrors its constant advancement through a development stage for both of its IP and prototype parts production. The revenue for the complete year increased to $1 million from $650,000 in 2012. In the last one year, the company was able to ship 18 prototypes as against 10 last year. Moreover, Liquidmetal Technologies Inc (OTCBB:LQMT) also announced the availability of a standard Liquidmetal injection molding solution from Engel, during this time.
mCig Inc (OTCBB:MCIG) shoots up by over 8% following its achievement of first quarterly profit in corporate history. The company reported adjusted Non-GAAP net income in order of $30,256. Its sales for the third quarter, ended on January 31, 2014 came in at $85,109, which reflected 24 inventory days on account of Chinese New Year and tremendous demand of the mCig 1.0. During this period, there has been a significant improvement in its Balance Sheet, as the shareholder equity grew to $1,321,736 from a negative ($210,087) in the same quarter in 2013. While its total debt came down to zero as against $196,000 in the previous year. In the reported quarter, the company also observed successful launch and rolloit of mCig Inc (OTCBB:MCIG) 2.0, which is one of the world’s portable and affordable Vaporizer.
